J-Bans Icu Care Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -888.67%
- Ebitda 2499.92%
- Net Worth -121.19%
- Total Assets 553.92%
About J-Bans Icu Care
J-Bans Icu Care Private Limited (JICPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 November 2020 (Four years and two months 9 days old ). Its registered office is in Delhi, Delhi.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Himanshu Tyagi and Nitin Tyagi serve as directors at the Company.
Company Details
-
LocationDelhi, Delhi
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909DL2020PTC373878
-
Company No.
373878
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Nov 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does J-Bans Icu Care Private Limited offer?
J-Bans Icu Care Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Injection, Digestive System Drugs & Medicines, Antacid Drugs, Brain & Nervous System Drugs, Psychotherapeutic Agents, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs.
Who are the key members and board of directors at J-Bans Icu Care?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Himanshu Tyagi
|
Director | 28-Nov-2020 | Current |
|
Nitin Tyagi
|
Director | 28-Nov-2020 | Current |
Financial Performance of J-Bans Icu Care.
J-Bans Icu Care Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 888.67% decrease in profit. The company's net worth observed a substantial decline by a decrease of 121.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of J-Bans Icu Care?
Unlock access to J-Bans Icu Care's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
J-Bans Intensive Care Private LimitedHimanshu Tyagi and Nitin Tyagi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at J-Bans Icu Care?
J-Bans Icu Care has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of J-Bans Icu Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped J-Bans Icu Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.